Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct;6(5):839-847.
doi: 10.21037/tau.2017.08.02.

Clinical scenarios for neoadjuvant chemotherapy of squamous penile cancer that is clinically node positive

Affiliations
Review

Clinical scenarios for neoadjuvant chemotherapy of squamous penile cancer that is clinically node positive

Mayer N Fishman. Transl Androl Urol. 2017 Oct.

Abstract

Squamous penile cancer may be localized to the phallus, metastatic to regional lymph nodes, or metastatic to distant lymph nodes or other organs. In the clinical situation of regional lymph node metastasis, a multimodality approach can have a big impact on outcomes. In particular, use of systemic chemotherapy as a neoadjuvant treatment is discussed, with several examples illustrating instances of regression and of resistance, and contrasting with adjuvant timing for use of chemotherapy. Radiation with coordinated combined chemotherapy is another complementary, locally directed approach that can be considered for men with squamous penile cancer with regional lymph node spread. The randomized trial InPACT (International Penile Cancer Adjuvant Chemotherapy Trial, NCT02305654) will enroll some of the squamous penile cancer patients with clinically node positive disease.

Keywords: Neoadjuvant; penile cancer.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Case described in the text: (A) pretreatment bilateral superficial adenopathy; (B) pretreatment left common iliac adenopathy, which later was a recurrence site; (C) post-chemotherapy PET scan—single left inguinal, negative node; (D) PET scan +12 months the left common iliac node still negative; (E) PET positive left common iliac lymph node recurrence at +15 months.
Figure 2
Figure 2
Case described in the text: a single superficial right inguinal, PET-positive finding. PET, positron emission tomography.
Figure 3
Figure 3
Case described in the text: preoperative scan and photograph of the ulcerated node and primary tumor. Photo courtesy of Dr. Wade Sexton, MD.
Figure 4
Figure 4
Case described in the text. (A-D) Radiographic appearance of multiple dermal nodules, some ulcerated (B), separate or contiguous with the primary region; (E) skin appearance; (F,G) micrographs illustrating dermal invasion, tumor cluster adjacent to a hair follicle (hematoxylin and eosin. F: 200×; G: 400×). Micrographs courtesy of Dr. Jasreman Dhillon, MD.
Figure 5
Figure 5
Case described in the text: (A,B,C) bilateral adenopathy at presentation; (D) after neoadjuvant chemoradiotherapy; (E) after neoadjuvant TIP ×3 cycles.
Figure 6
Figure 6
Case described in the text. Preoperative CT scan showed (A) right inguinal, (B) primary tumor, and (C) left inguinal disease; (D) scan (+44 days after penile surgery, +100 days from first scan) with growth in right inguinal node and (E) perineal skin; (F) left inguinal area appears radiologically negative.

References

    1. Bermejo C, Busby JE, Spiess PE, et al. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 2007;177:1335-8. 10.1016/j.juro.2006.11.038 - DOI - PubMed
    1. Pagliaro LC, Williams DL, Daliani D, et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 2010;28:3851-7. 10.1200/JCO.2010.29.5477 - DOI - PMC - PubMed
    1. Staging reference for penile cancer. Available online: https://www.cancer.gov/types/penile/hp/penile-treatment-pdq#section/_6
    1. Zapatero A, Martin De Vidales C, Arellano R, et al. Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy. Urology 2012;80:1056-62. 10.1016/j.urology.2012.07.045 - DOI - PubMed
    1. Strauss HG, Kuhnt T, Laban C, et al. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strahlenther Onkol 2002;178:378-85. 10.1007/s00066-002-0956-1 - DOI - PubMed

LinkOut - more resources